معرفی
Jonathan H. Marks is a Professor and Director of the Bioethics Program at Penn State University, with affiliate faculty roles in Penn State Law and the School of International Affairs. He holds advanced degrees from Oxford University, including an M.A., B.C.L., and LL.M., and is a barrister at Matrix Chambers, London. His career bridges academia, law, and global health ethics, with expertise in human rights law, bioethics, and corporate influence mitigation. Marks has advised international bodies on legal and ethical issues arising from state dissolution, environmental law, and pandemic triage. He previously held the Greenwall Fellowship in Bioethics and Health Policy at Georgetown/Johns Hopkins and participated in Harvard’s Safra Center initiative on institutional corruption (2009–2015).
His research focuses on the intersections of law, bioethics, and global health governance, addressing topics like corporate influence in public health, ethical challenges in armed conflict, and institutional integrity. He has contributed to high-profile cases, including representing Human Rights Watch in the Pinochet prosecution and advising on pharmaceutical regulation in the European Court of Justice. Marks frequently engages in policy discussions at WHO, the South Centre, and the Committee on World Food Security, advocating for ethical frameworks to counter corporate overreach in health systems.
Notable works include analyses of pandemic triage ethics, systemic corporate influence, and the ethics of partnerships between public institutions and private entities. He developed the 'Integrity Matrix,' an ethical tool for navigating industry relations in healthcare. His writings appear in legal journals, medical ethics forums, and mainstream outlets like The New York Times, addressing topics ranging from Guantanamo Bay detainee abuse to the ethics of neuroscience in national security.
Marks is a Hastings Center Fellow and has been featured in nationally broadcast panels on law and medical ethics. His advocacy emphasizes human rights-centered approaches to bioethical dilemmas, particularly in contexts of global inequality, crisis governance, and institutional complicity.
